UAE Eye Drops Market to grow with a CAGR of 5.41% through 2029
Increasing healthcare infrastructure and a supportive regulatory environment are the major drivers for the UAE Eye Drops Market.
According to TechSci Research report, “UAE
Eye Drops Market Industry Size, Share, Trends, Competition,
Opportunity and Forecast, 2019-2029”,
UAE Eye Drops Market was valued at USD 0.16 billion in 2023 and is anticipated
to witness an impressive growth in the forecast period with a CAGR of 5.41%
through 2029. This can be
due to collaborations and partnerships among leading companies with a diverse
approach to merge the expertise of individual companies and to strengthen their
position.
Consumer preferences for over the
counter (OTC) products can significantly drive the demand for eye drops.
OTC eye drops are readily
available without the need for a prescription. Consumers appreciate the
convenience of being able to purchase eye drops easily from pharmacies,
supermarkets, or online retailers, driving the demand for accessible solutions.
OTC eye drops often provide quick relief for common eye conditions such as
redness, dryness, and itching. Consumers prefer products that offer immediate
relief without the delay of obtaining a prescription, contributing to the
popularity of OTC eye drops. Many consumers prefer the ability to self-diagnose
and self-treat minor eye issues. OTC eye drops allow individuals to address
common symptoms without the need for a healthcare professional's intervention,
aligning with the trend of consumer empowerment in healthcare decisions.
The OTC segment offers a diverse range
of eye drops catering to various needs, including lubrication, redness relief,
allergy relief, and preservative-free formulations. This variety allows
consumers to choose products that align with their specific preferences and
requirements. OTC eye drops are generally more affordable than prescription
alternatives. Cost considerations play a crucial role in consumer
decision-making, and the affordability of OTC options encourages consumers to
purchase these products for minor eye conditions.
Browse over XX market data Figures and spread through XX Pages and an in-depth TOC on "UAE Eye Drops Market”
Supply
chain disruptions pose significant challenges for the UAE Eye Drops Market,
impacting the availability and distribution of eye care products. The
pharmaceutical industry often relies on a global supply chain for raw materials
and active pharmaceutical ingredients. Disruptions in the supply chain, whether
due to geopolitical issues, natural disasters, or other global events, can
affect the sourcing of essential components for eye drop production. Supply
chain disruptions can lead to delays in the manufacturing process. If key
components or ingredients are unavailable or face delays in transportation, it
can impact the production timelines of eye drop manufacturers. Transportation
disruptions, including delays in shipping and customs clearance, can affect the
timely delivery of finished eye drop products to distribution centers and
pharmacies. Logistical challenges can result from factors such as port
closures, transportation restrictions, or unexpected events affecting the
movement of goods.
UAE Eye Drops Market is
segmented based on Type, Drug Class, Disease Indication, Distribution Channel, End
User, and by region.
Based on the Drug Class,
UAE Eye
Drops Market is segmented into Antiallergy, Anti-inflammatory, Antiglaucoma,
Anti-VEGF, Others. Antiglaucoma drugs are medications used to manage and treat
glaucoma, a group of eye conditions characterized by increased intraocular
pressure (IOP), which can lead to optic nerve damage and vision loss if left
untreated. The goal of antiglaucoma drugs is to reduce intraocular pressure and
prevent or slow down the progression of glaucoma. There are various classes of
antiglaucoma drugs, each working through different mechanisms to achieve the
desired reduction in intraocular pressure. Prostaglandin analogs increase the outflow of
aqueous humor (the fluid within the eye) by relaxing the muscles in the eye's
drainage system (the trabecular meshwork). This results in improved drainage
and a reduction in intraocular pressure. Beta-blockers reduce the production of aqueous
humor by blocking beta receptors in the ciliary body, which is responsible for
producing the fluid. This leads to a decrease in intraocular pressure.
In 2023, the UAE Eye Drops Market largest share was held by Dry Eye Diseases segment and is predicted to continue expanding over the coming years. dry eye diseases are prevalent among the population in the UAE, there would be a higher demand for eye drops specifically formulated to address dry eye symptoms. This can contribute to the dominance of the Dry Eye Diseases segment in the market. Factors such as increased screen time, exposure to air conditioning, and environmental conditions can contribute to the rise in dry eye conditions. As lifestyles change, individuals may experience more instances of dry eyes, leading to a higher demand for corresponding eye drop solutions. Dry eye diseases are often associated with aging, and if the population in the UAE has a significant proportion of elderly individuals, the prevalence of dry eye conditions may be higher. This demographic trend can contribute to the dominance of the Dry Eye Diseases segment. Greater awareness of dry eye diseases and improved diagnostic capabilities can lead to more individuals seeking treatment for these conditions. Healthcare professionals may prescribe or recommend specific eye drops for dry eye relief, boosting the market share of this segment. Manufacturers may introduce innovative eye drop formulations tailored to address the unique needs of individuals with dry eye diseases. These products, backed by research and development efforts, can gain traction in the market, and contribute to the segment's dominance.
Some of the major companies operating in
the UAE Eye
Drops Market include:
- Johnson & Johnson Middle East FZ-LLC
- Pfizer Inc. (UAE)
- Sanofi (UAE)
- Novartis Middle East FZE
- Alcon UAE
Download free Sample Report
Customers
can also request 10% free customization on this report
“The UAE Eye Drops Market is witnessing a surge, driven by a growing emphasis on eye health. Trends indicate a shift towards preservative-free formulations, catering to sensitive eyes and reducing irritation risks. Demand for dry eye relief options is rising, with consumers seeking advanced solutions for digital eye strain. Innovations like hyaluronic acid-based drops offer prolonged moisture and comfort, appealing to a tech-savvy population. Furthermore, a preference for natural ingredients, such as herbal extracts, is notable among health-conscious consumers. The market's growth is also fueled by an aging population's increasing need for cataract and glaucoma treatments.," said Mr. Karan Chechi, Research
Director of TechSci Research, a research-based Global management consulting
firm.
UAE Eye Drops Market by Type
(Prescription, Over The Counter), By Drug Class (Antiallergy,
Anti-inflammatory, Antiglaucoma, Anti-VEGF, Others), By Disease Indication (Dry
Eye Diseases, Glaucoma, Eye Allergy, Eye Infections, Retinal Disorders,
Others), By Distribution Channel (Hospitals Pharmacy, Retail Pharmacy, Online
Pharmacy), By End User (Hospitals & Clinics, Homecare, Others), By Region, By Competition Forecast & Opportunities, 2018-2028F has evaluated the future growth potential of UAE
Eye Drops Market and provides statistics & information on market size, structure,
and future market growth. The report intends to provide innovative market
intelligence and help decision makers take sound investment decisions. Besides,
the report also identifies and analyzes the emerging trends along with
essential drivers, challenges, and opportunities in UAE Eye Drops Market.
Contact
TechSci Research LLC
420 Lexington Avenue, Suite 300,
New York, United States- 10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com